Marca Nominativa depositada no INPI em 28/07/2022 por VISCOFAN, S.A., processo nº 501690740, nas classes 01, 02, 05. Registro em vigor até 28/07/2032.
| Número do processo | 501690740 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 28/07/2022 |
| Data da concessão | 09/01/2024 |
| Vigência até | 28/07/2032 |
| Titular | VISCOFAN, S.A. |
| UF · País | — · ES |
Biological materials or preparations for 3D printers, hydrogels for cell culture; hydrogels for cell growth; cell culture media (other than for medical or veterinary use); nutritional agents for processing living cells (other than for medical use); culture media for microbiology; reagents for scientific and medical research; synthetic peptides (not for pharmaceutical purposes); synthetic peptide derivatives (not for pharmaceutical purposes); cells (other than for medical, veterinary or pharmaceutical use); cells or tissues in hydrogels (other than for medical, veterinary or pharmaceutical use); biologically compatible polymers, specifically hydrogels used to produce polymer networks used in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes; cell culture media for use in the biotechnological industry; cell culture media for use in non-medical research laboratories; biological preparations for use in cell culture, other than for medical and veterinary purposes; engineered living tissues and tissue arrays, namely, human and animal organs, connective tissue, epithelial tissue, muscular tissue and nervous tissue, and tissue arrays, for use in scientific and medical research; biologically compatible materials, specifically, hydrogels used to create polymeric networks used in the manufacture of living tissues; proteins in the form of raw materials for scientific and medical research.;
Inks of biological origin for printers; inks of biological origin for 3D printers.;
Hydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; cell culture media; nutritional agents for processing living cells; synthetic peptides; synthetic peptide derivatives; cells for medical, veterinary and pharmaceutical use; cells or tissues in hydrogels for medical, veterinary or pharmaceutical use; pharmaceutical preparations for use in 3D bio-printing of tissues and organs; pharmaceutical preparations based on cellulose nanofibers for use in 3D bio-printing of tissues and organs; regenerative tissue [pharmaceutical preparations]; cells for medical use; allogeneic human tissue; living cells for medical use; implantation of living tissue with controlled tissue regeneration; implants containing living tissue; implantable living tissue materials for use in guided tissue regeneration; skin grafts; surgical implants formed by living tissue; surgical implants of living tissues derived from stem cells; transdermal patches for the creation of skin for prostheses and skin grafts; living tissue for transplants; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular, and nervous tissues and organs, for medical purposes; biological molecules to assist in tissue engineering; hemostatic gel matrix preparations for wound treatment; natural biomaterials for the growth of bones, blood and tissues for medical purposes; pharmaceutical products for the regeneration of tissues, for the repair of tissues, for the treatment of tissues, whether human or animal; pharmaceutical preparations for the treatment of diseases of bones, cartilages, blood vessels, nerve cell degeneration, tendon and ligament degeneration, retinal degeneration, kidney degeneration; soft tissue degenerations, for diseases with abnormal cell growth; natural biomaterial for bone filling; natural biomaterial for cartilage filling; biological tissue cultures for medical use; biological tissue cultures for medical purposes; biological tissue grafts; bone and skin biological tissues impregnated with oxygen lines for tissue constructs applicable for increasing the cell survival in tissue intended for subsequent implants; gene therapy products, namely, genetically modified tissues for the transplant thereof; implantable stents containing living tissue to maintain the structure of the tissue; natural biomaterial for bone and tissue growth for medical purposes.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501690740 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.